Abstract:Two-dimensional cell lines display a wide range of usability and are readily available in a pandemic for identifying potential pathways of infection and tissue tropism of human pathogens. SARS-CoV-2 cultured in Vero-E6 cells (monkey kidney cells) showed high sequence homology and morphology similarity compared to viruses inoculated in human airway epithelial cells [3,4]. In addition, Vero-E6 cells enable higher level of SARS-CoV-2 amplification and infectivity compared to several human cell lines including A549, Calu-3, HUH7.9, HEK-293, and U251, suggesting its usefulness in generating viral stocks for translational research [5,6]. HEK-293 cells (human embryonic kidney cells) enabled the identification of S1 and S2 subunits of the SARS-CoV-2 transmembrane spike glycoprotein as the ligands that bind host receptors [7]. Using Vero-E6 cells, these subunits were also shown to be involved in viral fusion to host cell membrane to establish infection [8]. Consequently, these cell lines have been used to evaluate drugs and vaccines response [9]. In vitro cell models also enabled the identification of host factors that are involved in SARS-CoV-2 infection. Using parental BHK-21 cells (hamster-derived), the importance of angiotensin-converting enzyme 2 (ACE2) receptor in mediating infection has been discovered [7,10]. Using human HeLa cells, several proteases including transmembrane protease serine 2 and lysosomal protease cathepsin were identified as essential determinants of viral infectivity [7,10]. In addition, genome-wide CRISPR screens in various cell lines have identified functional pathways that are involved in SARS-CoV-2 infection. Screening in Vero-E6 cells led to the discovery of several proviral genes such as HMGB1 (which plays a role in regulating ACE2 expression, hence may affect viral entry into host cells) [11] and CDK4 (which is involved in cell cycle regulation that is crucial for viral replication) [12]. Using the same cell line and technique, the SWI/SNF chromatin remodeling complex has also been identified as proviral, while the Histone H3.3 complex was proposed to have an antiviral role in SARS-CoV-2 infection [11]. While the use of 2D cellular models in research has significantly advanced our understanding on SARS-CoV-2 pathogenesis, there are several noteworthy limitations. These cell lines do not mimic the complexity of the tissue microenvironment and the in vivo conditions in the human primary airway because they are often monocultures of immortalized cells, and some are of animal origins [13,14]. For example, they may not reproduce the antiviral responses in the lungs during an infection. In addition, long-term passaging of SARS-CoV-2 in permissive cell lines may induce mutations that alter the viruses' original pathogenicity and transmissibility, thus overtime may no longer be usable for research (Fig 1A) [6,15]. Ultimately, reducing capacities to translate novel basic science discoveries to clinical trials, and some of these limitations can be addressed using 3D cultures, which are discussed in later section.

3D Cell Culture Models in COVID-19 Times: A Review of 3D Technologies to Understand and Accelerate Therapeutic Drug Discovery

Human Organoids and Organs‐on‐Chips for Addressing COVID‐19 Challenges

Application of Human Induced Pluripotent Stem Cell-Derived Cellular and Organoid Models for COVID-19 Research

Bioengineered in Vitro Tissue Models to Study SARS-CoV-2 Pathogenesis and Therapeutic Validation

In Vitro and In Vivo Models for Studying SARS-CoV-2, the Etiological Agent Responsible for COVID-19 Pandemic

Organoid and microfluidics-based platforms for drug screening in COVID-19

Three-dimensional Cell Culture Models for Investigating Human Viruses

Airway models in a pandemic: Suitability of models in modeling SARS-CoV-2

Human organoid models to study SARS-CoV-2 infection

Three-Dimensional In Vitro Cell Culture Models for Efficient Drug Discovery: Progress So Far and Future Prospects

Three-Dimensional Human Alveolar Stem Cell Culture Models Reveal Infection Response to SARS-CoV-2

Cost‐effective 3D lung tissue spheroid as a model for SARS‐CoV‐2 infection and drug screening

Animal models for COVID-19: advances, gaps and perspectives

A Potential Ex Vivo Infection Model of Human Induced Pluripotent Stem Cell-3D Organoids Beyond Coronavirus Disease 2019.

3D tissue-engineered lung models to study immune responses following viral infections of the small airways

The breathtaking world of human respiratory in vitro models: Investigating lung diseases and infections in 3D models, organoids, and lung‐on‐chip

A Human Pluripotent Stem Cell-based Platform to Study SARS-CoV-2 Tropism and Model Virus Infection in Human Cells and Organoids

Methodology-centered review of molecular modeling, simulation, and prediction of SARS-CoV-2

Modeling of COVID-19 Disease Disparity in Gastric Organoids Reveals the Spatiotemporal Dynamics of SARS-CoV-2 Infectivity

Advances and gaps in SARS-CoV-2 infection models

Recent Advances of COVID-19 Modeling Based on Regenerative Medicine